BR112018015232A2 - composição de desbridamento para tratar feridas - Google Patents

composição de desbridamento para tratar feridas

Info

Publication number
BR112018015232A2
BR112018015232A2 BR112018015232-3A BR112018015232A BR112018015232A2 BR 112018015232 A2 BR112018015232 A2 BR 112018015232A2 BR 112018015232 A BR112018015232 A BR 112018015232A BR 112018015232 A2 BR112018015232 A2 BR 112018015232A2
Authority
BR
Brazil
Prior art keywords
debridement
debridement composition
present
aqueous gel
treat wounds
Prior art date
Application number
BR112018015232-3A
Other languages
English (en)
Inventor
Asculai Eilon
Geblinger Dafna
Kleyman Mery
Hanah Bartfeld Deborah
Original Assignee
Mediwound Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mediwound Ltd. filed Critical Mediwound Ltd.
Publication of BR112018015232A2 publication Critical patent/BR112018015232A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/54—Mixtures of enzymes or proenzymes covered by more than a single one of groups A61K38/44 - A61K38/46 or A61K38/51 - A61K38/53
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0014—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0052—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L33/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • C08L33/04—Homopolymers or copolymers of esters
    • C08L33/06—Homopolymers or copolymers of esters of esters containing only carbon, hydrogen and oxygen, which oxygen atoms are present only as part of the carboxyl radical
    • C08L33/08—Homopolymers or copolymers of acrylic acid esters
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
    • C08L71/02—Polyalkylene oxides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/22—Cysteine endopeptidases (3.4.22)
    • C12Y304/22031—Ananain (3.4.22.31)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/22—Cysteine endopeptidases (3.4.22)
    • C12Y304/22032—Stem bromelain (3.4.22.32)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A61L2300/254—Enzymes, proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/63—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from plants

Abstract

a presente invenção se refere a composições de desbridamento na forma de um gel aquoso. particularmente, a presente invenção se refere a uma composição de desbridamento que compreende uma mistura de enzimas proteolíticas, obtidas a partir de bromelaína presente em uma forma seca, e um carreador em gel aquoso, em que, antes do uso, a mistura de enzimas proteolíticas é misturada por adição com o carreador em gel aquoso para formar uma composição de desbridamento útil para desbridamento e tratamento de feridas crônicas.
BR112018015232-3A 2016-01-31 2017-01-30 composição de desbridamento para tratar feridas BR112018015232A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662289246P 2016-01-31 2016-01-31
US62/289,246 2016-01-31
PCT/IL2017/050107 WO2017130204A1 (en) 2016-01-31 2017-01-30 Debriding composition for treating wounds

Publications (1)

Publication Number Publication Date
BR112018015232A2 true BR112018015232A2 (pt) 2018-12-26

Family

ID=59397670

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018015232-3A BR112018015232A2 (pt) 2016-01-31 2017-01-30 composição de desbridamento para tratar feridas

Country Status (16)

Country Link
US (1) US11382958B2 (pt)
EP (1) EP3408387B1 (pt)
JP (1) JP6952353B2 (pt)
KR (1) KR102376345B1 (pt)
CN (1) CN108884453B (pt)
AR (1) AR107492A1 (pt)
AU (1) AU2017211721B2 (pt)
BR (1) BR112018015232A2 (pt)
CA (1) CA3012299C (pt)
ES (1) ES2909565T3 (pt)
IL (1) IL260780B (pt)
NZ (1) NZ745240A (pt)
RU (1) RU2732224C9 (pt)
TW (1) TWI758272B (pt)
WO (1) WO2017130204A1 (pt)
ZA (1) ZA201805489B (pt)

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4226854A (en) 1974-01-08 1980-10-07 Gerold K. V. Klein Debridement of devitalized tissue with hydrolytic enzyme product
US4197291A (en) 1974-01-08 1980-04-08 Gerold K. V. Klein Hydrolytic enzyme material
US4307081A (en) 1974-01-08 1981-12-22 Gerold K. V. Klein Enzyme mixture
US4329430A (en) 1979-06-04 1982-05-11 Klein Gerold K V Enzyme mixture
US4286064A (en) 1979-11-05 1981-08-25 Riker Laboratories, Inc. Process for isolating active debriding agent from bromelain
EP0039726A4 (en) 1979-11-05 1982-09-27 Riker Laboratories Inc ENZYMATIC DEBRIDING PROCESS.
US4668228A (en) 1985-03-12 1987-05-26 Johnson & Johnson Products, Inc. Debriding tape
US4784653A (en) 1987-06-22 1988-11-15 Johnson & Johnson Patient Care, Inc. Absorbent adhesive dressing
GB8724728D0 (en) * 1987-10-22 1987-11-25 Genzyme Corp Cysteine proteinase
US5271943A (en) 1989-10-27 1993-12-21 Scott Health Care Wound gel compositions containing sodium chloride and method of using them
US5804213A (en) 1991-10-09 1998-09-08 Lectec Corporation Biologically active aqueous gel wound dressing
US5393792A (en) 1991-11-20 1995-02-28 Advance Biofactures Of Curacao, N.V. High dosage topical forms of collagenase
EP0618811B1 (en) 1991-12-03 2000-04-05 KLEIN, Gerold K. V. Proteolytic mixture containing escharase and method of isolating same
IL103969A (en) 1991-12-03 1997-01-10 Gerold K V Klein Proteolytic mixture containing escharase and method of isolating same
SG42846A1 (en) 1992-06-30 1997-10-17 Cortecs Ltd Use of enzymes especially bromelain in the treatment of diarrhoea
JP3277342B2 (ja) 1992-09-02 2002-04-22 武田薬品工業株式会社 徐放性マイクロカプセルの製造法
GB9313188D0 (en) 1993-06-25 1993-08-11 Cortecs Ltd Medical use of enzymes
US5387517A (en) 1994-03-23 1995-02-07 Ethicon, Inc. Thiol activated protease from stem bromelain for treating devitalized tissue
US5876992A (en) 1996-07-03 1999-03-02 Molecular Biology Resources, Inc. Method and formulation for stabilization of enzymes
CN1252101A (zh) 1997-02-25 2000-05-03 科特克斯(英国)有限公司 菠萝蛋白酶成分
US20020102253A1 (en) 1997-02-25 2002-08-01 Mynott Tracey Lehanne Component of bromelain
JP4726296B2 (ja) 1998-02-27 2011-07-20 インスティチュート ストローマン アーゲー 創傷治癒のためのマトリックスタンパク質組成物
ES2182356T3 (es) 1998-07-15 2003-03-01 Ursapharm Arzneimittel Gmbh Uso de proteasas de bromelaina para inhibir la coagulacion de la sangre.
GB9819138D0 (en) 1998-09-02 1998-10-28 Cortecs Uk Ltd Nucleic acids and proteins from pineapple stem
US6548556B2 (en) 2000-12-27 2003-04-15 Healthpoint, Ltd. Stable enzymatic wound debrider
RU2180856C1 (ru) 2001-02-08 2002-03-27 Гаврилюк Борис Карпович Средство для лечения ран
KR20030055442A (ko) 2001-12-26 2003-07-04 주식회사 참 존 다당체를 이용한 안정화 효소의 제조방법 및 이들 안정화효소가 첨가된 조성물
EP1539225B1 (en) 2002-04-23 2012-08-22 Mediwound, Ltd. Apparatus and methods for use in enzymatic escharotomy in burn induced compartment syndrome
US8062661B2 (en) 2003-12-11 2011-11-22 Teikoku Pharma Usa, Inc. Methods and compositions for treating skin wounds
AU2005261276A1 (en) * 2004-07-13 2006-01-19 Mediwound Ltd. Compositions and methods for dermatological wound healing
IL165334A0 (en) * 2004-11-22 2006-01-15 Mediwound Ltd Debriding composition from bromelain and methods of producing same
BRPI0621744A2 (pt) 2006-06-21 2011-12-20 Zazil Ortiz Barba meio de cultivo para propagação de plantas de abacaxi (ananas comosus) in vitro; meio de cultivo para indução de mudas de abacaxi (ananas comosus) in vitro; e extrato cru de mudas de abacaxi (ananas comous)
EP2540831A3 (en) 2006-08-17 2013-04-10 Monsanto Technology, LLC Transgenic plants with enhanced agronomic traits
RU2348396C2 (ru) 2006-12-18 2009-03-10 Федеральное государственное образовательное учреждение высшего профессионального образования "Институт Федеральной службы безопасности Российской Федерации (г. Нижний Новгород)" (Институт ФСБ России) Композиция для лечения гнойных ран
EP2036978A1 (en) 2007-09-14 2009-03-18 URSAPHARM Arzneimittel GmbH & Co. KG Recombinant preparation of selected bromelain fractions
US20110098267A1 (en) * 2008-02-07 2011-04-28 Synta Pharmaceuticals Corporation Topical formulations for the treatment of psoriasis
DE202008001997U1 (de) * 2008-02-14 2008-04-03 Rosenberger Hochfrequenztechnik Gmbh & Co. Kg Kontaktfeder
JP5788323B2 (ja) 2008-10-02 2015-09-30 エル．アール． アールアンドディー リミテッド 界面層の創傷包帯
KR20170005192A (ko) * 2009-01-06 2017-01-11 큐어론 엘엘씨 스타필로코쿠스 아우레우스 감염의 치료 또는 예방 및 표면 상의 스타필로코쿠스 아우레우스의 박멸 또는 감소를 위한 조성물 및 방법
CN105031628B (zh) 2009-01-06 2020-10-02 加尔纳根有限责任公司 治疗或预防大肠杆菌导致的经口感染的组合物和方法
US20120121580A1 (en) 2009-07-28 2012-05-17 Merck Sharp & Dohme Corp. Methods for producing high concentration lyophilized pharmaceutical formulations
WO2012030750A2 (en) 2010-09-02 2012-03-08 Lubrizol Advanced Materials, Inc. Polymers and compositions
BR112014001439B1 (pt) 2011-07-20 2021-05-25 Mediwound Ltd. uso de um extrato proteolítico obtido de bromelaína para a preparação de um medicamento para o tratamento de uma doença do tecido conjuntivo
MX2015013244A (es) 2013-03-15 2016-04-15 Smith & Nephew Inc Pelicula soluble formadora de gel para suministrar agentes activos.
CN103285383B (zh) 2013-06-03 2015-01-07 海南通用同盟药业有限公司 一种包含菠萝蛋白酶的药物组合物及菠萝蛋白酶肠溶片
US9592280B2 (en) 2014-10-10 2017-03-14 Rochal Industries Llc Compositions and kits for enzymatic debridement and methods of using the same
CN105213107A (zh) 2015-08-24 2016-01-06 泰州市榕兴医疗用品股份有限公司 一种菠萝酶凝胶敷料
ES2936404T3 (es) 2016-04-18 2023-03-16 Mediwound Ltd Formulaciones para el desbridamiento de heridas crónicas

Also Published As

Publication number Publication date
RU2018129438A (ru) 2020-03-02
TWI758272B (zh) 2022-03-21
ZA201805489B (en) 2019-11-27
KR20180104138A (ko) 2018-09-19
CN108884453B (zh) 2022-07-29
AU2017211721A1 (en) 2018-08-30
EP3408387B1 (en) 2022-01-05
ES2909565T3 (es) 2022-05-09
JP6952353B2 (ja) 2021-10-20
NZ745240A (en) 2022-12-23
AR107492A1 (es) 2018-05-02
CA3012299A1 (en) 2017-08-03
CN108884453A (zh) 2018-11-23
EP3408387A1 (en) 2018-12-05
EP3408387A4 (en) 2019-11-13
KR102376345B1 (ko) 2022-03-18
US20190030140A1 (en) 2019-01-31
RU2018129438A3 (pt) 2020-05-25
RU2732224C9 (ru) 2021-06-18
AU2017211721B2 (en) 2022-01-13
IL260780B (en) 2021-02-28
RU2732224C2 (ru) 2020-09-14
TW201729834A (zh) 2017-09-01
CA3012299C (en) 2022-05-31
WO2017130204A1 (en) 2017-08-03
JP2019508392A (ja) 2019-03-28
US11382958B2 (en) 2022-07-12

Similar Documents

Publication Publication Date Title
DOP2018000182A (es) Benzamidas sustituidas con 1,3–tiazol–2–ilo
CL2018000106A1 (es) Moléculas de anticuerpo que se unen a cd45
BR112015023498A2 (pt) formulação para uma proteína terapêutica
CL2018000107A1 (es) Moléculas de anticuerpo que se unen a cd79
BR112017000313A2 (pt) sistema para o fornecimento de uma composição para tratamento bucal, composição para tratamento bucal, método para administrar uma composição para tratamento bucal
BR112015021999A2 (pt) inibidores de indoleamina 2,3-dioxigenase (ido)
BR112017002053A2 (pt) composto de acordo com a fórmula (i), composição farmacêutica, e usos de um composto
BR112018075140A2 (pt) composição na forma de uma solução aquosa injetável, e, formulação de dose única a um ph de 7 a 7,8
CL2015003602A1 (es) Composiciones y métodos para tratar anemia.
BR112013005679A2 (pt) imidazopiridazinas substituídas
EA201400903A1 (ru) Композиции глины
BR112014002000A2 (pt) membro de ranhura e lingueta redutor de som, processo de fabricação de redutor de som, e mistura redutora de som
CR20160433A (es) Nuevos compuestos
CL2012002624A1 (es) Compuestos derivados del complejo de hierro (iii)-beta-cetoamida; composición que los contiene; medicamento que los comprende; y su uso rara el tratamiento y la profilaxis de síntomas de deficiencia de hierro y las amnemias por deficiencia de hierro y sus síntomas asociados.
BR112019001039A2 (pt) composição para uso no tratamento de transtorno depressivo maior
BR112017011476A2 (pt) composição baseada em aminoácidos para recuperação de fibroelastina em tecidos conjuntivos dérmicos e uso
SV2017005466A (es) Pirazolpiridinaminas como inhibidores de mknk1 y mknk2
EA201400748A1 (ru) Композиция для обработки семян
BR112016010875A8 (pt) Composição útil para a promoção da fertilidade feminina
BR112014000542A2 (pt) composições de peroxidase eosinofílica e métodos de uso das mesmas
PH12015502163B1 (en) Nutritional compositions including calcium beta-hydroxy-beta-methylbutyrate, casein phosphopeptide, and protein
AR099500A1 (es) Composición para el desmucilaginado enzimático de aceite
EA201591996A1 (ru) Способы и композиции для заживления раны
CL2019002574A1 (es) Moduladores de la expresión de pcsk9.
BR112016022722A2 (pt) pró-fármacos de inibidores da transcriptase reversa de hiv

Legal Events

Date Code Title Description
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements